CITIGROUP INC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,073,857
-23.2%
338,756
+20.4%
0.00%0.0%
Q2 2023$1,398,379
-49.0%
281,364
-49.3%
0.00%
-50.0%
Q1 2023$2,743,394
+26.7%
555,343
+61.3%
0.00%0.0%
Q4 2022$2,166,094
-61.3%
344,371
-33.5%
0.00%
-50.0%
Q3 2022$5,592,000
+103.6%
517,789
+114.9%
0.00%
+100.0%
Q2 2022$2,747,000
+152.9%
240,965
+102.2%
0.00%
+100.0%
Q1 2022$1,086,000
-72.6%
119,165
-55.1%
0.00%
-50.0%
Q4 2021$3,959,000
+21.6%
265,384
+109.5%
0.00%0.0%
Q3 2021$3,255,000
-37.1%
126,655
-36.1%
0.00%
-33.3%
Q2 2021$5,171,000
+18.2%
198,288
+60.0%
0.00%0.0%
Q1 2021$4,376,000
+667.7%
123,961
+449.2%
0.00%
Q4 2020$570,000
+40.4%
22,571
+109.7%
0.00%
Q3 2020$406,000
-81.0%
10,765
-78.4%
0.00%
-100.0%
Q2 2020$2,136,000
+140.8%
49,870
+9.3%
0.00%
+100.0%
Q1 2020$887,000
-24.3%
45,616
+1.1%
0.00%0.0%
Q4 2019$1,172,000
+1.5%
45,112
+6.4%
0.00%0.0%
Q3 2019$1,155,000
-53.8%
42,379
-54.5%
0.00%
-50.0%
Q2 2019$2,502,000
+2133.9%
93,169
+2298.2%
0.00%
Q1 2019$112,000
-26.3%
3,885
-31.0%
0.00%
Q4 2018$152,0005,6320.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders